0     

Borders JC, Sevitz JS, Curtis JA, Vanegas-Arroyave N, Troche MS. Quantifying impairments in swallowing safety and efficiency in progressive supranuclear palsy and Parkinson's disease. Dysphagia. 2023;:. PMID: 36763187.

0     

Gadot R, Vanegas Arroyave N, Dang H, Anand A, Najera RA, Taneff LY, et al. Association of clinical outcomes and connectivity in awake versus asleep deep brain stimulation for Parkinson disease. J Neurosurg. 2023;138(4):1016-27. PMID: 35932263.

0     

Troche MS, Curtis JA, Sevitz JS, Dakin AE, Perry SE, Borders JC, et al. Rehabilitating cough dysfunction in Parkinson's disease: A randomized controlled trial. Mov Disord. 2023;38(2):201-11. PMID: 36345090.

0     

Vanegas-Arroyave N, Jankovic J. Spinal cord stimulation for gait disturbances in Parkinson's disease. Expert Rev Neurother. 2023;23(7):651-9. PMID: 37345383.

0     

Borders JC, Curtis JA, Sevitz JS, Vanegas-Arroyave N, Troche MS. Immediate effects of sensorimotor training in airway protection (smTAP) on cough outcomes in progressive supranuclear palsy: A feasibility study. Dysphagia. 2022;37(1):74-83. PMID: 33515312.

0     

Enver N, Borders JC, Curtis JA, Sevitz JS, Vanegas-Arroyave N, Troche MS. The role of vocal fold bowing on cough and swallowing dysfunction in progressive supranuclear palsy. Laryngoscope. 2021;131(6):1217-22. PMID: 32687232.

0     

Feeney MP, Xu Y, Surface M, Shah H, Vanegas-Arroyave N, Chan AK, et al. The impact of COVID-19 and social distancing on people with Parkinson's disease: A survey study. NPJ Parkinsons Dis. 2021;7(1):10. PMID: 33479241.

0     

Klopstock T, Videnovic A, Bischoff AT, Bonnet C, Cif L, Comella C, et al. Fosmetpantotenate randomized controlled trial in pantothenate kinase-associated neurodegeneration. Mov Disord. 2021;36(6):1342-52. PMID: 33200489.

0     

Radmard S, Ortega RA, Ford B, Vanegas-Arroyave N, McKhann GM, Sheth SA, et al. Using computerized spiral analysis to evaluate deep brain stimulation outcomes in Parkinson disease. Clin Neurol Neurosurg. 2021;208:106878. DOI: https://doi.org/10.1016/j.clineuro.2021.106878.

0     

Wang Q, Akram H, Muthuraman M, Gonzalez-Escamilla G, Sheth SA, Oxenford S, et al. Normative vs. patient-specific brain connectivity in deep brain stimulation. Neuroimage. 2021;224:117307. PMID: 32861787.

0     

Rutherford BR, Choi J, Slifstein M, O'Boyle K, Abi-Dargham A, Brown PJ, et al. Neuroanatomical predictors of L-DOPA response in older adults with psychomotor slowing and depression: A pilot study. J Affect Disord. 2020;265:439-44. PMID: 32090770.

0     

Cassidy CM, Zucca FA, Girgis RR, Baker SC, Weinstein JJ, Sharp ME, et al. Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain. Proc Natl Acad Sci U S A. 2019;116(11):5108-17. PMID: 30796187.

0     

Pretegiani E, Vanegas-Arroyave N, FitzGibbon EJ, Hallett M, Optican LM. Evidence from Parkinson's disease that the superior colliculus couples action and perception. Mov Disord. 2019;34(11):1680-9. PMID: 31633242.

0     

Rutherford BR, Slifstein M, Chen C, Abi-Dargham A, Brown PJ, Wall MW, et al. Effects of L-DOPA monotherapy on psychomotor speed and [(11)c]raclopride binding in high-risk older adults with depression. Biol Psychiatry. 2019;86(3):221-9. PMID: 31178096.

0     

Alcalay RN, Wolf P, Levy OA, Kang UJ, Waters C, Fahn S, et al. Alpha galactosidase A activity in Parkinson's disease. Neurobiol Dis. 2018;112:85-90. PMID: 29369793.

0     

Lauro PM, Vanegas-Arroyave N, Huang L, Taylor PA, Zaghloul KA, Lungu C, et al. DBSproc: An open source process for DBS electrode localization and tractographic analysis. Hum Brain Mapp. 2016;37(1):422-33. PMID: 26523416.

0     

Rossi PJ, Gunduz A, Judy J, Wilson L, Machado A, Giordano JJ, et al. Proceedings of the Third Annual Deep Brain Stimulation Think Tank: A review of emerging issues and technologies. Front Neurosci. 2016;10:119. PMID: 27092042.

0     

Vanegas N, Zaghloul K, Hallett M, Lungu C. Leg movements during general anesthesia. Mov Disord Clin Pract. 2016;3(5):510-2. PMID: 28239614.

0     

Vanegas-Arroyave N, Lauro PM, Huang L, Hallett M, Horovitz SG, Zaghloul KA, et al. Tractography patterns of subthalamic nucleus deep brain stimulation. Brain. 2016;139(Pt 4):1200-10. PMID: 26921616.

0     

Vanegas-Arroyave N, Panyakaew P, Lamichhane D, Shulman L, Hallett M. Possible functional moving toes syndrome. Tremor Other Hyperkinet Mov (N Y). 2016;6:352. PMID: 27144090.

0     

Park JE, Vanegas-Arroyave N, Hallett M, Lungu C. A woman with a novel mutation of THAP1 with a prominent response to deep brain stimulation of the globus pallidus internus. JAMA Neurol. 2015;72(11):1369. PMID: 26415042.

0     

Vanegas N, Zaghloul KA. Deep brain stimulation for substance abuse. Curr Behav Neurosci Rep. 2015;2(2):72-9. DOI: 10.1007/s40473-015-0037-2.

0     

Yang AI, Vanegas N, Lungu C, Zaghloul KA. Beta-coupled high-frequency activity and beta-locked neuronal spiking in the subthalamic nucleus of Parkinson's disease. J Neurosci. 2014;34(38):12816-27. PMID: 25232117.

0     

Sublette ME, Segal-Isaacson CJ, Cooper TB, Fekri S, Vanegas N, Galfalvy HC, et al. Validation of a food frequency questionnaire to assess intake of n-3 polyunsaturated fatty acids in subjects with and without major depressive disorder. J Am Diet Assoc. 2011;111(1):117-23 e1-2. PMID: 21185973.

0     

Hoyos-Orrego A, Massaro-Ceballos M, Ospina-Ospina M, Gomez-Builes C, Vanegas-Arroyave N, Tobon-Pereira J, et al. Serological markers and risk factors for hepatitis B and C viruses in patients infected with human immunodeficiency virus. Rev Inst Med Trop Sao Paulo. 2006;48(6):321-6. PMID: 17221128.

0     

Henao JA, Vanegas N, Cano OD, Hiromi JC, Rugeles MT. [The human immunodeficiency virus type 1 and the developing central nervous system]. Biomedica. 2005;25(1):136-47. PMID: 15962910.

0     

Hoyos-Orrego A, Vanegas N. Western blot false negative test in a patient with AIDS. Infectio. 2003;7(3):173-6.

0     

Hoyos-Orrego A, Vanegas N, Paez E. Epidemiology of hepatitis C virus in Colombia. Acta Med Colomb. 2002;27(4):209-20.